Plastic and Reconstructive Surgery, Global Open (Jul 2021)

Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations

  • Craig F. Teller, MD,
  • Annie Chiu, MD,
  • Cameron D. Chesnut, MD,
  • Deborah Sherman, MD,
  • José Raul Montes, MD,
  • Sara Gaspard, MD,
  • Terrence Keaney, MD,
  • Neil S. Sadick, MD,
  • Steve Yoelin, MD,
  • Sara Sangha, PhD,
  • Sachin M. Shridharani, MD

DOI
https://doi.org/10.1097/GOX.0000000000003668
Journal volume & issue
Vol. 9, no. 7
p. e3668

Abstract

Read online

Background:. Submental fat can be reduced with ATX-101 (deoxycholic acid injection), a customizable and minimally invasive alternative to liposuction. In the years since its approval, the treatment patterns of ATX-101 have evolved. Methods:. A panel of experienced physicians from the United States gathered to generate best practices for the use of ATX-101 in submental contouring. Results:. The expert panel provided their insights on appropriate patient selection, managing patient expectations of ATX-101 treatment outcomes, and adverse events, and guidance on ATX-101 administration for optimal outcomes are presented here. Conclusion:. These best clinical practices on the use of ATX-101 for the reduction of submental fat should enable physicians to enhance the patient treatment experience and outcomes.